Recalls, Market Withdrawals, & Safety Alerts > Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

Recalls, Market Withdrawals, & Safety Alerts > Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

A new MedWatch Safety Alert was just added to the FDA Recall webpage.  TOPIC: Levoleucovorin Injection by Mylan Institutional: Recall - Due to the Presence of Particulate Matter AUDIENCE: Health Professional, Risk Manager, Pharmacy ISSUE: Mylan Institutional is conducting a voluntary nationwide recall of two lots of Levoleucovorin Injection, 250 mg/25 mL to the consumer/user level. The lots were manufactured by Alidac Pharmaceuticals Limited and distributed by Mylan Institutional. The Levoleucovorin Injection is being recalled due to the presence of particulate matter identified as copper salts. The particulate matter was discovered during 12-month stability testing.

Read Alert